David M Martin

Title: The Innovative Contributions of David M Martin

Introduction

David M Martin is a notable inventor based in Stockport, GB. He has made significant contributions to the field of chemistry, particularly in the development of novel chemical processes and compounds. With a total of 5 patents to his name, Martin's work has implications in the pharmaceutical industry, especially concerning angiotensin II inhibitors.

Latest Patents

Among his latest patents, Martin has developed biphenyl-tetrazole intermediate compounds. This invention provides a novel chemical process for the manufacture of quinoline, pyridine, and imidazole derivatives, which are crucial in creating non-toxic salts that act as angiotensin II inhibitors. The process involves the removal of an electron-deficient phenyl group or a pyridyl or pyrimidyl group from a specific compound. Additionally, he has patented a chemical process for the manufacture of certain imidazo[4,5-b]pyridine derivatives, which also serve as angiotensin II inhibitors. This process similarly involves the removal of specific groups from defined compounds, showcasing Martin's innovative approach to chemical synthesis.

Career Highlights

David M Martin has had a distinguished career, working with prominent companies such as Imperial Chemical Industries Limited and Zeneca Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in chemical processes.

Collaborations

Throughout his career, Martin has collaborated with notable colleagues, including Andrew Peter Thomas and Stanley A Lee. These collaborations have likely enriched his work and led to further innovations in his field.

Conclusion

David M Martin's contributions to the field of chemistry through his patents and career achievements highlight his role as an influential inventor. His work continues to impact the development of important pharmaceutical compounds.